GB0913042D0 - Antigen complexes - Google Patents

Antigen complexes

Info

Publication number
GB0913042D0
GB0913042D0 GB0913042A GB0913042A GB0913042D0 GB 0913042 D0 GB0913042 D0 GB 0913042D0 GB 0913042 A GB0913042 A GB 0913042A GB 0913042 A GB0913042 A GB 0913042A GB 0913042 D0 GB0913042 D0 GB 0913042D0
Authority
GB
United Kingdom
Prior art keywords
antigen complexes
antigen
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0913042A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0913042A priority Critical patent/GB0913042D0/en
Publication of GB0913042D0 publication Critical patent/GB0913042D0/en
Ceased legal-status Critical Current

Links

GB0913042A 2009-07-27 2009-07-27 Antigen complexes Ceased GB0913042D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0913042A GB0913042D0 (en) 2009-07-27 2009-07-27 Antigen complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0913042A GB0913042D0 (en) 2009-07-27 2009-07-27 Antigen complexes

Publications (1)

Publication Number Publication Date
GB0913042D0 true GB0913042D0 (en) 2009-09-02

Family

ID=41066888

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0913042A Ceased GB0913042D0 (en) 2009-07-27 2009-07-27 Antigen complexes

Country Status (1)

Country Link
GB (1) GB0913042D0 (en)

Similar Documents

Publication Publication Date Title
ZA201104545B (en) Anti-siglec-15 antibody
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
PT2581113T (en) Anti-tim-3 antibody
PT3342786T (en) Anti-dll3 antibody
PL2616489T3 (en) Anti-hutnfr1 antibody
IL221416A0 (en) Alpha-emititng complexes
ZA201104540B (en) Usirna complexes
IL222852A0 (en) Anti-fgfr2 antibodies
GB201000467D0 (en) Antibodies
IL221371A0 (en) Anti-lrp6 antibodies
EP2427496A4 (en) Anti-vegf-d antibodies
IL225571A0 (en) Antibodies
IL225667A0 (en) Novel antigen
PT2585216T (en) Complexes
GB201020738D0 (en) Antibodies
PL2603528T3 (en) Fab-glycosylated antibodies
GB201002238D0 (en) Antibodies
GB0920324D0 (en) Antibodies
GB0905972D0 (en) Antibodies against IL-17BR
EP2499256A4 (en) Anti-c-mpl antibodies
GB201003483D0 (en) Gold complexes
GB2473934B (en) Anti-VEEV antibody
GB0902916D0 (en) Antibody therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)